Find Academic Supervisors

• Biomedical Signal and Image Processing
• Cardiovascular and Neural Modeling
• Physiologically-interpretable Artificial Intelligence systems
• +5 more

Gaetano Valenza is an Associate Professor of Bioengineering at the University of Pisa, Italy, where he leads the Neuro-Cardiovascular Intelligence Lab at the Enrico Piaggio Research Centre. He holds affiliations with the Neuroscience Statistics Research Laboratory at MIT and has served as a Research Fellow at Harvard Medical School and Massachusetts General Hospital. His academic work spans bioengineering, computational physiology, and affective computing. His research focuses on statistical and nonlinear biomedical signal and image processing , cardiovascular and neural modeling , and physiologically interpretable artificial intelligence . He develops wearable systems for physiological monitoring, with applications in autonomic nervous system assessment, brain-heart interactions, and mental health. His work has led to novel metrics such as the Sympathetic and Parasympathetic activity indices derived from ECG. The 15 most recent publications reflect a consistent trend in brain-heart interplay , complexity analysis of physiological signals , explainable AI in healthcare , and virtual reality applications in mental health . His work integrates advanced signal processing, nonlinear dynamics, and machine learning to decode emotional and cognitive states from physiological data. Dr. Valenza is a Senior Member of IEEE and serves on several technical committees. He is an active editorial leader, currently serving as Associate Editor for IEEE-EMBC , Plos One , Complexity , and Scientific Reports , and has guest-edited special issues in Philosophical Transactions of the Royal Society A and IEEE Journal of Biomedical and Health Informatics . He has led or participated in numerous international research projects, including FP7 and H2020 initiatives such as NEVERMIND and EXPERIENCE. He teaches courses in Biostatistics, Probability & Biostatistics, and Advanced Image Processing at the University of Pisa. As lab head and project coordinator, he leads a multidisciplinary team working on neuro-cardiovascular intelligence, wearable systems, and AI-driven mental health interventions.

Virend SomersView profile

Professor

• Cardiovascular Medicine
• Sleep Apnea
• Neurocirculatory Control
• +9 more

Virend Somers, M.D., Ph.D. , is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, with primary appointments in the Department of Cardiovascular Medicine, and joint appointments in Physiology & Biomedical Engineering and Nephrology & Hypertension. He directs the Cardiovascular and Sleep Facilities within Mayo Clinic's Center for Clinical and Translational Science. Education: MB ChB, University of Natal D.Phil., University of Oxford Resident, Internal Medicine, University of Iowa Fellow, Cardiovascular Diseases, University of Iowa Hospitals and Clinics Research Interests: Dr. Somers' research centers on neural and vascular mechanisms in circulatory control, particularly in sleep disorders such as obstructive and central sleep apnea, hypertension, obesity, and heart failure. His team investigates autonomic nervous system regulation, chemoreflex responses, and vascular biology in humans. His work bridges basic physiology with clinical applications to improve cardiovascular outcomes. Publication Trends: His recent publications (2021–2025) show a strong emphasis on sleep-cardiovascular interactions, including blood pressure regulation during sleep, cardiovascular mortality in the context of comorbidities like obesity and COVID-19, and neurocardiological mechanisms in arrhythmias and syncope. His work frequently appears in high-impact journals such as Sleep , Journal of the American Heart Association , and Journal of Physiology . Scientific Awards: Alice Sheets Marriott Professor (2016) CTSA Mentor of the Year (2012) Distinguished Scientist in Cardiopulmonary Physiology, American College of Chest Physicians (2017) Stanford University World's Top 2% Scientists (2021) Lifetime Achievement Award, South African Society of Sleep Medicine (2012) Doctor Honoris Causa, Masaryk University (2007) Advising and Grants: Dr. Somers has mentored numerous trainees who have won national awards. His research is supported by four NIH R01 grants, a Dana Foundation grant, and a NATO grant. His leadership in collaborative research spans institutions in the U.S., Europe, and South Africa. Labs and Teams: He leads the Cardiovascular Facility and Sleep Facility at Mayo Clinic’s Center for Clinical and Translational Science, fostering interdisciplinary research on sleep and cardiovascular disease.

• Industrial Automation
• Control Systems
• Machine Learning Applications
• +5 more

Valeriy Vyatkin is a Professor at the Department of Electrical Engineering and Automation, Aalto University. His research focuses on advancing industrial automation, control systems, and their integration with emerging technologies like machine learning and digital twins. He specializes in standards such as IEC 61499, addressing interoperability, formal verification, and performance optimization in distributed automation systems. Key research interests include: Physics-informed machine learning for industrial processes (e.g., steel rolling, reservoir engineering) Formal methods for control system validation and safety-critical applications Development of adaptive automation frameworks for Industry 5.0 challenges, including human-robot collaboration and energy systems Interoperability between legacy and modern industrial standards (OPAS, OPC UA) Recent work emphasizes real-time simulation, FPGA-based control prototyping, and AI-driven solutions for energy efficiency and sustainability in manufacturing, horticulture, and process industries. Publications span topics like robotic walker design, probabilistic model checking, and decentralized learning management systems. He collaborates on EU and industry-funded projects, focusing on digital twin implementation, edge computing, and virtual commissioning. His team develops tools for automated code generation, system migration, and anomaly detection in complex industrial settings.

• Cognitive Neuroscience
• Decision Making
• Noradrenergic System
• +3 more

Professor Sander Nieuwenhuis (Leiden University) specializes in Cognitive Neuroscience of Decision Making through behavioral, EEG, and pharmacological approaches. His work bridges prefrontal cortex function and noradrenergic system mechanisms in human cognition. Studied cognitive psychology (Groningen) and earned PhD (Amsterdam, 2001) International experience: Cambridge University (visiting research), Princeton University (postdoc) Research focuses on noradrenaline's role in attention, decision-making, and cognitive control via: Locus coeruleus-norepinephrine system dynamics Phasic vs. tonic alertness effects Cognitive task performance under neuromodulator deficiency Neuroprotective pathways in Alzheimer's models Recent publications analyze DBH deficiency (Jepma et al., 2011) and attentional blink mechanisms (Nieuwenhuis et al., 2005). His Temporal Attention Lab integrates fMRI, genetics, and computational modeling . Teaching leadership includes: Chair of Research Master Program Committee Coordinator of Scientific Writing courses

Andrew C. ShinView profile

Assistant Professor

• Metabolic Health
• Neuroendocrinology
• Branched-Chain Amino Acid (BCAA) Metabolism
• +5 more

Andrew C. Shin is an Assistant Professor at Texas Tech University within the Department of Nutritional Sciences . His work bridges metabolic health , neuroendocrinology , and neurodegenerative diseases , with a focus on how the brain regulates glucose homeostasis , BCAA metabolism , and bariatric surgery mechanisms . Ph.D. in Neuroscience, Michigan State University (2008) Postdoctoral Fellow, Pennington Biomedical Research Center and Icahn School of Medicine at Mount Sinai Dr. Shin’s research explores the neural pathways involved in appetite regulation , nutrient partitioning , and metabolic resistance . His NIH-funded projects investigate insulin signaling in POMC neurons , BCAA dynamics , and nicotine’s metabolic effects . Recent work highlights the role of the autonomic nervous system in BCAA regulation and its implications for obesity and diabetes . His 15 most recent publications reflect a focus on AI applications in nutrition , BCAA-related pathologies , Alzheimer’s disease , and metabolic surgery outcomes . Key themes include neuroendocrine control , nutritional interventions , and environmental impacts on metabolism . Scientific Awards NIH K01 Award Dr. Shin directs the Mouse Metabolic Phenotyping Facility and collaborates on synbiotic trials for cognitive aging . His work spans basic science and translational research , addressing metabolic disorders and their neurological consequences .

Samuel FountainView profile

Professor

• Pharmacology
• Ion Channels
• Cardiometabolic Physiology
• +12 more

Professor Samuel Fountain is a leading academic in pharmacology at the University of East Anglia, where he serves as Chair of Pharmacology within the School of Biological Sciences. He holds additional leadership roles as Associate Pro-Vice-Chancellor of the UEA Doctoral College and has previously served as Associate Dean for Postgraduate Research and Director of the Biomedical Research Centre. He is actively supervising multiple PhD students and securing major research funding. BSc (Hons) Pharmacology, University of Leeds (1997–2000) MRC-funded PhD, University of Leeds (2000–2004) Wellcome Trust Research Associate, University of Manchester (2004–2008) BBSRC David Phillips Fellow, University of Leeds (2008–2010) Lecturer to Professor of Pharmacology, University of East Anglia (2010–present) His research focuses on the role of ion channels—particularly P2X receptors—in vascular and adipose tissues, with implications for cardiometabolic diseases. His work integrates pharmacology, physiology, and molecular biology to understand neurovascular and neuroadipose communication, receptor-ligand interactions, and drug discovery. He employs techniques such as pressure myography, patch-clamp electrophysiology, calcium imaging, and molecular modelling. The analysis of his recent publications reveals a strong emphasis on purinergic signalling, ion channel pharmacology, and autonomic control of blood vessels and fat tissue. His work bridges basic science with translational applications, particularly in hypertension, obesity, and metabolic syndrome. Collaborations with AstraZeneca, Merck, and the British Heart Foundation underscore the clinical and pharmaceutical relevance of his research. Notable scientific recognition includes the prestigious BBSRC David Phillips Fellowship. He also contributes to the academic community through editorial roles, including as Editor of Purinergic Signalling , and as a member of the British Pharmacological Society and The Physiological Society. Professor Fountain actively mentors postdoctoral researchers and PhD students, several of whom are funded by BBSRC, BHF, and AstraZeneca iCASE awards. His lab is supported by significant grants from the British Heart Foundation, BBSRC, and industry partners, enabling cutting-edge research in vascular and metabolic pharmacology. He leads multiple active projects on neurovascular transmission, purinergic control, and drug discovery for P2X receptors. His research group operates within the Cells and Tissues research theme at UEA and utilizes advanced experimental platforms including human tissue studies, high-throughput screening, and computational ligand docking. The lab fosters interdisciplinary collaboration between pharmacologists, physiologists, and clinicians, positioning it at the forefront of autonomic and metabolic research.

Raj RajakumarView profile

Associate Professor

• Molecular Neuroscience
• Schizophrenia Mechanisms
• Autism Neurobiology
• +3 more

Dr. Raj Rajakumar is an Associate Professor at Western University's Department of Anatomy and Cell Biology, cross-appointed with the Department of Psychiatry. His work focuses on molecular mechanisms underlying schizophrenia symptoms and autism neurobiology, employing animal models to study drug effects and neural signaling. He holds a PhD from the University of Western Ontario, with prior degrees in M.B.B.S. (University of Peradeniya) and M.Sc. (University of Western Ontario). Educations: Ph.D., Anatomy and Cell Biology, University of Western Ontario M.Sc., Anatomy and Cell Biology, University of Western Ontario M.B.B.S., Medicine, University of Peradeniya Research Interests: Molecular pathways in schizophrenia symptom manifestation Neurobiological basis of autism spectrum disorders Pharmacological interventions using antipsychotics and psychotropic drugs Neuroimaging techniques (fMRI, MRS) to study brain connectivity His research combines molecular biology, neuroanatomy, and behavioral assays in animal models to explore schizophrenia pathophysiology. Recent work includes maternal immune activation effects on fetal brain development, cannabinoid impact on executive function, and white matter inflammation in Alzheimer's models. Collaborations with Dr. W.J. Rushlow and others highlight translational research in neuropsychiatric disorders. Key contributions include automated MRI algorithms for medial temporal lobe analysis and longitudinal studies of glutamatergic deficits in schizophrenia. His work bridges basic science with clinical applications in mental health. Dr. Rajakumar's lab focuses on understanding brain circuitry disruptions in psychiatric disorders, with implications for novel therapeutic targets. No formal advisees are listed, but his research team actively engages in interdisciplinary collaborations.

Scott MoffatView profile

Professor

• Spatial Cognition
• Navigation
• Cognitive Aging
• +2 more

Scott Moffat is a Professor of Psychology at Georgia Institute of Technology, affiliated with the School of Psychology. He holds a Ph.D. in Psychobiology & Clinical Neuropsychology from the University of Western Ontario (1998). His research focuses on the cognitive neuroscience of aging, particularly the interplay between hormonal systems (e.g., cortisol, testosterone, insulin) and spatial cognition, navigation, and brain aging. He employs neuroimaging (fMRI/PET), behavioral assessments, and biochemical assays to study these topics. A key innovation is his use of virtual reality environments to evaluate spatial memory in older adults. Research interests emphasize stress physiology, including cortisol’s role in hippocampal atrophy and Alzheimer’s risk, testosterone’s impact on cognitive aging, and insulin’s effects on neural function. His work highlights individual differences in cognitive aging and the biological mechanisms underlying such variability. He has published extensively on spatial navigation strategies, age-related neural changes, and the application of virtual technologies for cognitive assessment. Labs/Teams: Director of the Cognitive Neuroscience of Aging Lab at Georgia Tech’s Center for Advanced Brain Imaging. His lab investigates brain-behavior relationships in aging using multimodal neuroimaging and endocrine measures.

Anand KrishnanView profile

Assistant Professor

• Nerve-tumor interface
• Nerve regeneration
• Cancer biology
• +5 more

Dr. Anand Krishnan serves as Assistant Professor in the Department of Anatomy, Physiology and Pharmacology at the University of Saskatchewan's College of Medicine, where he leads research on nerve-tumor interfaces and neural macrophage biology. His work bridges neuroscience and oncology to identify therapeutic targets for cancer and neurodegenerative disorders. Education: Postdoctoral Fellow, Division of Neurology, University of Alberta, Canada Postdoctoral Fellow, Clinical Neurosciences, University of Calgary, Canada PhD in Biotechnology (Cancer Biology), Rajiv Gandhi Centre for Biotechnology, India Master of Pharmacy (Pharmacology), Manipal University, India Pharma R&D Experience: Orchid Chemicals and Pharmaceuticals Limited; Alembic Pharmaceuticals Limited Dr. Krishnan's research program investigates two core areas: molecular mapping of tumor-nerve interfaces to uncover novel therapeutic targets, and defining the roles of self-renewing resident macrophages in nervous system homeostasis and disease. His lab employs proteomics, murine models, and in vitro neuronal cultures to explore how tumors and nerves mutually support growth through neural invasion and autonomic signaling. Analysis of his 2020-2024 publications reveals consistent focus on neuro-oncology mechanisms, particularly peripheral nerve regeneration pathways (Myc interactome, growth-primed DRG), tumor-nerve crosstalk (sympathetic signaling in prostate cancer), and neurodegenerative targets (MANF). Key methodologies include comparative proteomics, molecular mapping, and drug repurposing screens. Research Funding: Natural Sciences and Engineering Research Council (NSERC) Cancer Research Society (CRS) CIHR Institute of Cancer Research Breast Cancer Society of Canada (BCSC) Prostate Cancer Fight Foundation (PCFF) & Ride for Dad Saskatchewan Health Research Foundation (SHRF) College of Medicine Research Award (CoMRAD) CoMBRIDGE Fund Start-up Research Fund Based at Saskatoon City Hospital within the Cameco MS Neuroscience Research Centre, the Krishnan Lab trains students supported by NSERC USRA, Dean's project fellowships, OVDR Biomedical research fellowships, and Mitacs awards. The lab's strategic location adjacent to the Meewasin Valley provides collaborative opportunities for translational neuroscience research focused on nerve regeneration and cancer therapeutics.

• Neuroscience
• Neuropharmacology
• Neurodegenerative Diseases
• +5 more

Professor Aideen Sullivan is Head of the Department of Anatomy and Neuroscience at University College Cork (UCC). With a career spanning over two decades at UCC, she leads research on neuroprotective therapies for Parkinson's disease, focusing on growth factors, stem cell applications, and epigenetic mechanisms. She established Ireland's first BSc in Neuroscience and co-developed the cross-College BSc in Medical and Health Sciences (CK707). BSc (First Class Honours) in Pharmacology, University College Dublin (1992) PhD in Neuropharmacology, University of Cambridge (1995) Her research program investigates Parkinson's disease through five key themes: viral vector delivery of neurotrophic factors, molecular mechanisms of neuroprotection, biomarker discovery, neuronal degeneration models, and stem cell-based treatments. She has secured significant grants from Health Research Board, Enterprise Ireland, and the Wellcome Trust. Recent publications (2022-2020) emphasize epigenetic regulation (HDAC inhibitors), microbiome-gut-brain axis interactions, and novel neurotrophic strategies. Articles highlight GDF5's neuroprotective effects, miRNA modulation, and molecular pathways like BMP-Smad and p38-MAPK. Scientific awards include: Postgraduate Certificate in Teaching and Learning (UCC, 2006) FETAC Certificate in Peer-Mentoring (2010) Leadership Foundation Aurora Programme Scholarship (2015) Over €2 million in research grants She mentors undergraduate and postgraduate students, chairs UCC's Athena SWAN 'Flexible Working' group, and serves as Editor-in-Chief of Neuronal Signaling . Her work spans laboratory research, public engagement, and educational innovation.

Neil GarrettView profile

Assistant Professor

• Cognitive Psychology
• Decision-Making
• Belief Updating
• +7 more

Neil Garrett is a Research Lecturer (Assistant Professor) in the Psychology Department at the University of East Anglia, where he is also a Visiting Lecturer and member of the Cognition, Action and Perception and Social Cognition Research Groups. He is actively involved in research and accepts PhD students, indicating ongoing academic engagement. Research Lecturer, Psychology Department, University of East Anglia Visiting Lecturer, School of Psychology, UEA Member, Cognition, Action and Perception Research Group Member, Social Cognition Research Group Neil Garrett's research focuses on how beliefs and motivation emerge from learning processes. He employs computational modeling, neuroimaging, behavioral experiments, online games, and economic theory to understand decision-making and its neurobiological basis. His work spans cognitive and affective neuroscience, with applications in clinical disorders such as depression and schizophrenia. His recent publications reveal a strong emphasis on belief updating, optimism bias, decision heuristics, and neural mechanisms of motivation. Articles span journals like Nature Communications , eLife , and Journal of Neuroscience , reflecting interdisciplinary and high-impact research. Topics include biased belief updating, foraging decisions, habenula-insular circuits, and computational psychiatry, indicating a cohesive research program in cognitive-affective neuroscience. Sir Henry Wellcome Research Fellow UCL IMPACT Scholar in Experimental Psychology Published in Nature Neuroscience , Nature Communications , eLife , PNAS Contributor to Aeon Magazine , The Conversation , and NBC Garrett has led research projects funded by the Wellcome Trust and British Academy, focusing on information sharing motivations and neural mechanisms in clinical disorders. He collaborates widely, particularly with Tali Sharot, and has advised or co-authored with multiple early-career researchers. He is active in academic dissemination, having spoken at the Pavlovian Society conference. His lab investigates cognitive and neural mechanisms of belief and decision-making, likely involving computational and behavioral methodologies.

Tiago PeçanhaView profile

Senior Lecturer

• Cardiovascular Physiology
• Rheumatoid Arthritis
• Physical Activity Interventions
• +3 more

Dr. Tiago Peçanha is a Senior Lecturer in Human Cardiovascular Physiology at Manchester Metropolitan University's School of Sport, Exercise and Health Sciences. He holds a PhD from the University of São Paulo and has conducted postdoctoral research at prestigious institutions including the University of São Paulo and Liverpool John Moores University. His research focuses on neural regulation of cardiovascular responses to exercise, effects of physical activity in older adults and individuals with rheumatic diseases, and vascular health in autoimmune conditions. Education: PhD in Sport and Exercise Science (University of São Paulo, 2017) MSc in Exercise Physiology (Federal University of Juiz de Fora, 2012) BSc in Sport and Exercise Science (Federal University of Juiz de Fora, 2008) Professional Memberships: Fellow of the Higher Education Academy British Society for Rheumatology Physiological Society American Physiological Society Research Interests: Dr. Peçanha explores cardiovascular and cerebrovascular physiology, particularly in contexts of aging, rheumatic diseases (e.g., rheumatoid arthritis), and physical inactivity. His work addresses mechanisms linking exercise to reduced cardiovascular risk in chronic inflammatory conditions and investigates interventions to mitigate sedentary behavior's health impacts. Key themes include autonomic nervous system regulation, vascular function, and translational approaches to improving patient outcomes. Grants & Projects: He leads projects funded by Health Innovation Manchester (£9,989), Lupus UK (£24,992), Alzheimer’s UK (£3,318), and the Royal Society (£20,000). These focus on physical activity interventions for lupus patients, cognitive dysfunction in systemic lupus erythematosus, and cerebrovascular responses to exercise in aging populations. Teaching: Delivers modules in Sport and Exercise Physiology, Health and Exercise Physiology, and Introduction to Physiology at undergraduate levels. Supervises BSc and MSc dissertation students. Labs/Teams: Collaborates with the Manchester Institute of Sport and the Health and Exercise Science Research Group, advancing clinical and applied research in rheumatology and cardiovascular health.

• Cardiovascular Physiology
• Exercise and Aging
• Hypertension
• +3 more

Joel D. Trinity, PhD, is an Associate Professor in the Department of Internal Medicine at the University of Utah and holds adjunct appointments in the Department of Nutrition and Integrative Physiology and the Department of Physical Therapy & Athletic Training. He is affiliated with the Geriatrics Division and the Utah Vascular Research Laboratory (UVRL), where he has been a member since 2009. Education: PhD – The University of Texas at Austin MA – The University of Texas at Austin BA – Occidental College BA – University of California, Santa Cruz Postdoctoral Fellowship – University of Utah Advanced Fellowship – George E. Whalen VA Medical Center Research Focus: Dr. Trinity’s laboratory employs integrative in-vivo and in-vitro methodologies to investigate how aging and chronic diseases—particularly hypertension, heart failure, COPD, and peripheral artery disease—impair vascular function and blood-flow regulation. His work emphasizes the triad of neural control, oxidative stress, and endothelial signaling (especially nitric oxide) in determining vascular health across the lifespan. Publications Snapshot: From 2021-2025, Dr. Trinity has published extensively on human cardiovascular responses to exercise, vascular aging, and the vascular consequences of COVID-19. A recurring theme is the translational evaluation of passive leg movement as a non-invasive probe of endothelial function, with studies spanning young adults to older patients with multiple comorbidities. Funding & Collaborations: While specific grant numbers are not provided, the breadth of multi-center collaborations (e.g., RECOVER Consortium for long COVID) and continuous publication output indicate active federal and institutional funding. His laboratory hosts interdisciplinary trainees bridging geriatrics, exercise physiology, and vascular biology. Laboratory & Teams: Dr. Trinity conducts research within the Utah Vascular Research Laboratory (UVRL), leveraging state-of-the-art Doppler ultrasound, plethysmography, and metabolic assays to dissect vascular control mechanisms in human participants and murine models.

Peter CatchesideView profile

Professor

• Sleep Medicine
• Respiratory Physiology
• Obstructive Sleep Apnea
• +7 more

Professor Peter Catcheside is a distinguished sleep and respiratory physiologist at Flinders University's College of Medicine and Public Health, where he serves as a Full Member of both the Flinders Health and Medical Research Institute Sleep Health (formerly the Adelaide Institute for Sleep Health) and the Medical Device Research Institute within the College of Science and Engineering. Based in the Mark Oliphant Building's 6-bed sleep research facility in Bedford Park, South Australia, he maintains an active research program with over 265 research outputs spanning more than two decades. His primary research interests focus on obstructive sleep apnea, respiratory control mechanisms, arousal from sleep, environmental noise effects on sleep, upper airway neuromuscular control, cardiovascular disturbances related to sleep disorders, and circadian physiology. Professor Catcheside's work bridges clinical research with technical and computing expertise to investigate the mechanisms and consequences of disturbed breathing and sleep. His current research predominantly centers on improving treatments and diagnostic methods for sleep breathing disorders including obstructive sleep apnea, problem snoring, and central sleep apnea, as well as understanding how respiratory problems and environmental noise exposure affect sleep quality. Analysis of his 15 most recent publications reveals a strong emphasis on clinical applications of sleep research, with particular focus on sleep apnea diagnostics and treatment, cardiovascular consequences of sleep-disordered breathing, circadian rhythm analysis, and the relationship between sleep quality and various health outcomes including diabetes and athletic performance. His research employs sophisticated methodologies including polysomnography, advanced data modeling, and physiological measurements. Over 265 research outputs with consistent publication record through 2025 6877 total citations reflecting significant impact in the field 47 h-index demonstrating substantial scholarly influence Active supervision of students across multiple disciplines including Medicine, Physiology, Engineering, and Psychology Professor Catcheside has completed principal supervisions in Physiology (3) and associate supervisions across Medicine (3), Physiology (3), Engineering (2), and Psychology (1). His research program contributes to multiple UN Sustainable Development Goals, particularly in health and wellbeing. His work combines sleep and respiratory physiology measurements with circadian and cardiovascular physiology expertise to address complex questions in sleep medicine.

Chadi CalargeView profile

Professor

• Child and Adolescent Psychiatry
• Developmental Pediatrics
• Psychopharmacology
• +6 more

Chadi Calarge, M.D. is a Professor at Baylor College of Medicine and leads the Calarge Lab affiliated with Texas Children’s Hospital and the Meyer Center for Developmental Pediatrics and Autism . His research focuses on the biological basis of mental illness in children and adolescents , particularly examining interactions between mental health and physical outcomes, such as growth patterns, bone health, metabolic changes, and gut-brain axis dynamics. Research Themes : Psychiatric medication effects on growth hormone signaling and longitudinal growth Role of iron deficiency and gut permeability in internalizing disorders Genetic moderators of antipsychotic and SSRI side effects Microbiome and inflammatory markers in adolescent depression Metformin as an adjunct for antipsychotic-induced metabolic issues Key Publications (2015-2024) span psychopharmacology , developmental neuroscience , and pediatric psychiatry , with recurring themes of growth inhibition from SSRIs and antipsychotics iron deficiency as a biomarker in psychiatric disorders microbiome alterations linked to mental health genetic risk factors for medication side effects metabolic monitoring standards in youth psychiatric care